New Delhi, Sept. 10 -- CEPI (Coalition for Epidemic Preparedness Innovations) CEO, Richard Hatchett, is in India for CEPI's board meeting, its first in the country. In an exclusive interaction with HT, Hatchett spoke about the chances of getting a vaccine ready for field trials for the Bundibugyo virus in next four to six weeks, with India contributing significantly in manufacturing of one of the front-runners. Edited excerpts: We are having the first meeting of our board in India. We planned to have a board meeting in India in 2020, but then Covid happened. India was one of our original funder countries. This outbreak, unfortunately, has spread dramatically. Africa CDC has said that the area where the current outbreak is occurring is about...